What is bagassosis, and what are its clinical presentation, diagnostic criteria, and management?

Bagassosis: Occupational Hypersensitivity Pneumonitis from Bagasse Dust

Bagassosis is a form of hypersensitivity pneumonitis (allergic alveolitis) caused by inhalation of bagasse dust—the fibrous residue remaining after sugarcane processing—typically contaminated with thermophilic actinomycetes, particularly Thermoactinomyces vulgaris. 1, 2

Clinical Presentation

Acute Form

• Respiratory distress developing 4-8 hours after exposure (late-phase reaction)
• Systemic symptoms: fever, chills, malaise
• Dyspnea and cough without wheezing
• Physical examination: bibasilar crackles may be present
• Symptoms typically appear after a latency period following initial sensitization 3, 2

Chronic Form

• Progressive dyspnea with continued exposure
• Reduced ventilatory capacity, particularly in workers with regular, continuous exposure
• May present with minimal symptoms despite ongoing exposure 4

Radiographic Features

• Acute phase: diffuse nodular infiltrates throughout both lung fields
• Chronic phase: interstitial fibrosis pattern
• Complete radiographic resolution possible with cessation of exposure and treatment 3

Diagnostic Criteria

Essential Components

1. Occupational history: exposure to bagasse in sugar processing, paper manufacturing, or related industries 1

2. Inhalation challenge testing: Late systemic reactions (4-8 hours post-exposure) to bagasse extract or Thermoactinomyces vulgaris extract confirm diagnosis 2

3. Histopathology (when biopsy performed):

   • Interstitial infiltration with lymphocytes and macrophages
   • Foreign body giant cell granulomas containing bagasse fibers
   • Interstitial fibrosis with reticulin and collagen fibers in chronic cases
   • Lymph node changes suggesting immunological reaction 5

Important Diagnostic Pitfall

Serum precipitins against bagasse extracts are NOT diagnostically useful—they occur equally in affected patients, unaffected exposed workers, and non-exposed controls 2. Do not rely on precipitin testing for diagnosis.

Pulmonary Function Testing

• Restrictive pattern with reduced lung volumes
• Decreased diffusing capacity
• Indian workers show particularly significant reductions in ventilatory capacity with chronic exposure 4

Management Algorithm

Immediate Intervention

1. Remove from exposure immediately—this is the single most critical intervention
2. Corticosteroid therapy for symptomatic patients:
   • Initiate systemic corticosteroids (specific dosing not established in literature, but follow standard HP protocols)
   • Duration: typically 4 months based on case reports 3
   • Monitor for clinical and radiographic improvement

Expected Outcomes

• Complete recovery is typical with exposure cessation and corticosteroid treatment 3
• Radiographic clearing occurs over months
• Symptoms resolve significantly with appropriate therapy 1

Monitoring During Treatment

• Serial chest radiographs to document resolution
• Pulmonary function tests to assess improvement
• Clinical symptom assessment

Critical Management Points

Cessation of exposure usually results in complete recovery, making early recognition and removal from the workplace essential 3. The disease results from synergistic action between bagasse fibers and contaminating actinomycetes (Thermoactinomyces vulgaris), with an immunological hypersensitivity mechanism 2, 5.

Complications to Anticipate

• Pneumothorax can occur as a complication of diagnostic procedures (transbronchial biopsy)—manage with intercostal drainage 1
• Progressive fibrosis with continued exposure
• Death has been reported in severe cases without appropriate intervention 6

Prevention

• Adequate protective equipment for workers exposed to bagasse dust
• Recognition that even low dust concentrations can cause disease in sensitized individuals 4
• Industrial hygiene measures in organized sectors have reduced incidence, but small-scale operations remain at risk 1